Search & Filter

We are more susceptible to infection at certain times of the day as our body clock affects the ability of viruses to replicate and spread between cells, suggests new research from the University of Cambridge. The findings, published in the Proceedings of the National Academy of Sciences, may help explain why shift workers, whose body clocks are routinely disrupted, are more prone to health problems, including infections and chronic disease.

The net ingredient cost (NIC) of drugs for diabetes has increased by £88.0 million in 2015/16, bringing the annual primary care prescribing spend on this drug classification to £956.7 million €“ around £2.6 million per day, new figures by NHS Digital have revealed.

An ingenious new device from medical manufacturer Clement Clarke International (CCI) aims to change the way young children are taught to inhale their medication, the manufacturer has said. 

A significant improvement in hyperglycaemia in patients with type 2 diabetes poorly controlled on one or more oral antidiabetic agents was seen in the first-in-human study of RevitaTM duodenal mucosal resurfacing (Revita DMR) - a new 60 minute non-surgical procedure - according to data published in the current issue of Diabetes Care.

Recent research by mental health charity Mind has revealed that almost nine in ten (88%) of primary care workers find their work life stressful, compared to 56% of the wider UK workforce.

Scientists who mapped the teenage brain have said changes in the brain's structure during adolescence could help to explain why the first symptoms of mental illness appear before adulthood.

Following the recent CE mark approval for Biotronik's E-Series pacemaker, a UK woman has become the first person in Europe to be implanted with the streamlined device.

Neurology services have improved for people living with Parkinson's disease, results from the largest ever Parkinson's services audit have revealed.

The European Medicines Agency (EMA) has recommended granting marketing authorisations in the European Union (EU) for two medicines for the treatment of advanced renal cell carcinoma.

A new programme will transform the way healthcare professionals spot the early signs of illness will be rolled out across Sunderland's care homes. 

The Scottish Medicines Consortium (SMC) has published advice accepting six new medicines for routine use by NHS Scotland, including treatments for mantle cell lymphoma, chronic lymphocytic leukaemia and high cholesterol.

The European Medicines Agency (EMA) has recommended granting marketing authorisations in the European Union (EU) for two medicines for the treatment of advanced renal cell carcinoma.

A study into a prebiotic that aims to reduce the severity of exercise-induced asthma has posted positive results, its producers have said.

Following the recent CE mark approval for Biotronik's E-Series pacemaker, a UK woman has become the first person in Europe to be implanted with the streamlined device.

Carers UK has called on the government to be bold as it develops a new strategy to improve the lives of unpaid carers.